Search Results - "Gehlkopf, Eve"
-
1
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
Published in Blood (02-11-2023)“…Background : Brexucabtagene autoleucel (brexu-cel) was recently approved for adult patients with relapsed/refractory (R/R) B-cell precursor acute lymphoblastic…”
Get full text
Journal Article -
2
Coagulopathy Following Chimeric Antigen Receptor T Cell Therapy in R/R Adult B Cell Malignancies: A Single Center Experience
Published in Blood (23-11-2021)“…Background. Immunotherapy with chimeric antigen receptor T (CAR-T cells) is a new therapeutic approach approved for patients with relapsed/refractory (R/R)…”
Get full text
Journal Article -
3
Gilteritinib activity in refractory or relapsed FLT3-mutated acute myeloid leukemia patients previously treated by intensive chemotherapy and midostaurin: a study from the French AML Intergroup ALFA/FILO
Published in Leukemia (01-01-2023)“…The real-world efficacy and safety of gilteritinib was assessed in an ambispective study that included 167 R/R FLT3 -mutated AML patients. Among them, 140…”
Get full text
Journal Article -
4
Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report
Published in Blood (02-11-2023)“…Introduction T-cell acute lymphoblastic leukemia (T-ALL) is an orphan disease diagnosed mostly in adolescent and young adults. In adult population, 5-10% of…”
Get full text
Journal Article -
5
Combination Chemotherapy in Patients with Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasms (BPDCN): First Results of a Prospective French Trial (LpDessai)
Published in Blood (02-11-2023)“…Introduction Blastic plasmacytoid dendritic cell neoplasms (BPDCN) are now well-characterized diseases clearly referenced in the 5 th edition of the World…”
Get full text
Journal Article -
6
-
7
Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy
Published in Cancers (25-08-2021)“…CD19-directed CAR T-cells have been remarkably successful in treating patients with relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and…”
Get full text
Journal Article -
8
Myeloablative Versus Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia in Patients with Prior Myelodysplastic Syndrome/ Myeloproliferative Disorders: An ALWP of EBMT Study
Published in Blood (08-12-2017)“…▪ Secondary acute myeloid leukemia (sAML) includes a heterogeneous group of diseases evolved from myelodysplasia, myeloproliferative disorders (MDS/ MPN), bone…”
Get full text
Journal Article -
9
Outcomes of Cord Blood Transplantation for Adult Patients with Hodgkin Lymphoma, a Eurocord and EBMT Lymphoma Working Party Study
Published in Blood (08-12-2017)“…Allogeneic stem cell transplantation represents an alternative for relapsed or refractory patients (pts) with Hodgkin Lymphoma (HL). In this setting, only…”
Get full text
Journal Article -
10
Efficacy and tolerance of brexucabtagene autoleucel in adults with R/R B-ALL: a GRAALL study from the DESCAR-T registry
Published in Blood advances (12-11-2024)Get full text
Journal Article -
11
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
Published in Journal of clinical medicine (12-07-2020)“…Donor lymphocyte infusion (DLI) is used to prevent or treat haematological malignancies relapse after allogeneic stem cell transplantation (allo-SCT)…”
Get full text
Journal Article -
12
Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study
Published in Biology of blood and marrow transplantation (01-11-2018)“…•UCBT is feasible in heavily pretreated patients with HL.•Outcomes are poor for patients not in CR at the time of UCBT.•Cyclophosphamide + fludarabine + 2 Gy…”
Get full text
Journal Article Web Resource